All Type of News
New screening procedure on OTC products to be eyed
The Korea Food and Drug Administration has unveiled its plan to legislate a bill to separately establish a new screening procedure concerning the safety and efficacy of over-the-counter (OTC) products, aside from the ...
160 items to benefit from health insurance
The Ministry of Health, Welfare and Family Affairs has announced that 160 drugs will be newly eligible for health insurance from next month.
Included in the 160 items are Janssen Korea’s Prezista injection and Daco...
Manufacturers moving to raise OTC products
Handok Pharm is poised to raise its Festal price once again amid the latest inflationary pressures stemming from surging oil prices and rising raw material costs.
Sources say the wholesaler price of Festal has been...
Launching of new prescription pain treatment to be delayed
Janssen Korea says Jurnista prolonged-release tablets (hydromorphone HCl), a new prescription treatment for severe pain, will not be available on market in September, as its price negotiation with the National Health ...
Hyundai to release anti-oxidant therapy in 2014Hyundai Pharm has recently entered into a licensing agreement with Nippon Zoki Pharmaceutical Co. to develop and commercialize a new anti-oxidant (code name: HD003) for treatmen...
|
Boryung, Metholatum clash on topical analgesics & anti-inflammatory agents
With the race for leadership in the next-generation display market between Boryung Pharm and Metholatum Co. getting increasingly fierce, signals of a market division are looming large at competitors.
Boryung has la...
Drug makers urged to nurture promotional professionals
Domestic pharmaceutical firms should focus on nurturing professionals in the promotion sector as the number of these professional has been on the gradual decrease due to pharmaceutical firms’ lack of recognition.
A...
Drug license and management rules revised
The Korea Food and Drug Administration says it has recently revised drug license and management rules.
Under the revised rules, it will be possible for a drug manufacturer to change the manufacturing site of active...
Private health insurance cannot be exclusive possession of the rich
Critics say private health insurance may be exclusively used by wealthy people, but such claim is groundless, according to a local researcher for the Korea Development Institute.
Yoon Hee-sook, a KDI research fello...
Positive list system to face opposition
The so-called positive system is triggering a backlash from the domestic pharmaceutical industry.
Under the new drug-pricing policy called the “positive list system,” better-priced and more effective medicines will...
